Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse

Stem Cells

Volumn 25, Issue 4, 2007, Pages 875-884

  Chan, Jerry ^a,b,d   Waddington, Simon N ^a,c   O'Donoghue, Keelin ^a,b   Kurata, Hitoshi ^a   Guillot, Pascale V ^a   Gotherstrom, Cecilia ^a   Themis, Michael ^a   Morgan, Jennifer E ^a   Fisk, Nicholas M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FETUS CELL; HUMAN; MESENCHYMAL STEM CELL; MOUSE; MUSCLE CELL; NONHUMAN; PROTEIN EXPRESSION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

MUS;

EID: 34147151813     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0694     Document Type: Article

References (71)

1. Melacini P, Vianello A, Villanova C et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul Disord 1996;6:367-376.
2. Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 2007;1772:229-237.
3. Sampaolesi M, Biressi S, Tonlorenzi R et al. Cell therapy of primary myopathies. Arch Ital Biol 2005;143:235-242.
4. Sampaolesi M, Torrente Y, Innocenzi A et al. Cell therapy of alphasarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003;301:487-492.
5. Torrente Y, Belicchi M, Sampaolesi M et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-195.
6. Dezawa M, Ishikawa H, Itokazu Y et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005;309:314-317.
7. Rodriguez AM, Pisani D, Dechesne CA et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 2005;201:1397-1405.
8. Ferrari G, Cusella De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530.
9. Gussoni E, Soneoka Y, Strickland CD et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-394.
10. Mackenzie TC, Shaaban AF, Radu A et al. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. J Pediatr Surg 2002;37:1058-1064.
11. Gussoni E, Bennett RR, Muskiewicz KR et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 2002;110:807-814.
12. De Bari C, Dell'Accio F, Vandenabeele F et al. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 2003;160:909-918.
13. Kinoshita I, Roy R, Dugre FJ et al. Myoblast transplantation in monkeys: control of immune response by FK506. J Neuropathol Exp Neurol 1996;55:687-697.
14. Huard J, Roy R, Guerette B et al. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 1994;17:224-234.
15. Skuk D, Goulet M, Roy B et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65:371-386.
16. Sancho S, Mongini T, Tanji K et al. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy. N Engl J Med 1993;329:915-920.
17. Beggs AH, Koenig M, Boyce FM et al. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45-48.
18. Boyd JD, Hamilton WJ. The Human Placenta. Cambridge: Hefer; 1970.
19. Haynes BF, Scearce RM, Lobach DF et al. Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Exp Med 1984;159:1149-1168.
20. Shields LE, Lindton B, Andrews RG et al. Fetal hematopoietic stem cell transplantation: a challenge for the twenty-first century. J Hematother Stem Cell Res 2002;11:617-631.
21. Campagnoli C, Roberts IA, Kumar S et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396-2402.
22. Chan J, O'Donoghue K, de la Fuente J et al. Human Fetal Mesenchymal Stem Cells as Vehicles for Gene Delivery. STEM CELLS 2005;23:93-102.
23. Guillot P, Gotherstrom C, Chan J et al. Human first trimester fetal mesenchymal stem cells (MSC) are more primitive than adult MSC: pluripotency markers, growth kinetics and telomere status. STEM CELLS 2007 (in press).
24. Chan J, O'Donoghue K, Gavina M et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 2006;24:1879-1891.
25. Orlandi F, Damiani G, Jakil C et al. The risks of early cordocentesis (12-21 weeks): analysis of 500 procedures. Prenat Diagn 1990;10:425- 428.
26. Surbek DV, Tercanli S, Holzgreve W. Transabdominal first trimester embryofetoscopy as a potential approach to early in utero stem cell transplantation and gene therapy. Ultrasound Obstet Gynecol 2000;15:302-307.
27. Surbek DV, Young A, Danzer E et al. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy. Am J Obstet Gynecol 2002;187:960-963.
28. C, Ringden O, Westgren M et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 2003;32:265-272.
29. Taylor PA, McElmurry RT, Lees CJ et al. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood 2002;99:1870-1872.
30. Rebel VI, Miller CL, Eaves CJ et al. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 1996;87:3500-3507.
31. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999;27:1418-1427.
32. Hayashi S, Abdulmalik O, Peranteau WH et al. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol 2003;31:176-184.
33. Polkinghorne J. Review of the guidance on the research use of fetus and fetal material. CM 762. London: Her Majesty's Stationary Office; 1989.
34. Lu QL, Partridge TA. A new blocking method for application of murine monoclonal antibody to mouse tissue sections. J Histochem Cytochem 1998;46:977-984.
35. Flake AW, Roncarolo MG, Puck JM et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806-1810.
36. Flake AW. In utero stem cell transplantation for the treatment of genetic diseases. Schweiz Med Wochenschr 1999;129:1733-1739.
37. Wengler GS, Lanfranchi A, Frusca T et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996;348:1484-1487.
38. Westgren M, Ringden O, Bartmann P et al. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency. Am J Obstet Gynecol 2002;187:475-482.
39. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996;93:2264-2271.
40. Goodnow CC, Sprent J, Fazekas de St Groth B et al. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005;435:590-597.
41. Flake AW. In utero stem cell transplantation. Best Pract Res Clin Obstet Gynaecol 2004;18:941-958.
42. Peranteau WH, Endo M, Adibe OO et al. Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood 2007;109:1331-1333.
43. Pixley JS, Tavassoli M, Zanjani ED et al. Transplantation in utero of fetal human hematopoietic stem cells into mice results in hematopoietic chimerism. Pathobiology 1994;62:238-244.
44. Oppenheim SM, Muench MO, Gutierrez-Adan A et al. Hematopoietic stem cell transplantation in utero produces sheep-goat chimeras. Blood Cells Mol Dis 2001;27:296-308.
45. Shields LE, Bryant EM, Easterling TR et al. Fetal liver cell transplantation for the creation of lymphohematopoietic chimerism in fetal baboons. Am J Obstet Gynecol 1995;173:1157-1160.
46. Shields LE, Gaur L, Delio P et al. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates. STEM CELLS 2004;22:759-769.
47. Flake AW, Harrison MR, Adzick NS et al. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986;233:776-778.
48. Zanjani ED, Flake AW, Rice H et al. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 1994;93:1051-1055.
49. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. Br Med J 1963;5365:1107-1109.
50. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2002;100:600-611.
51. Abbott JD, Huang Y, Liu D et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004;110:3300-3305.
52. Neuss S, Becher E, Woltje M et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. STEM CELLS 2004;22:405-414.
53. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-981.
54. Bittner RE, Schofer C, Weipoltshammer K et al. Recruitment of bonemarrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol 1999;199:391-396.
55. François S, Bensidhoum M, Mouiseddine M et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 2006;24:1020-1029.
56. Chou SH, Kuo TK, Liu M et al. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice. J Orthop Res 2006;24:301-312.
57. Niyibizi C, Wang S, Mi Z et al. The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Mol Ther 2004;9:955-963.
58. Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004;117(Pt 23):5655-5664.
59. Heymann MA, Rudolph AM. Control of the ductus arteriosus. Physiol Rev 1975;55:62-78.
60. Lapidos KA, Chen YE, Earley JU et al. Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J Clin Invest 2004;114:1577-1585.
61. Le Blanc K, Gotherstrom C, Ringden O et al. Fetal mesenchymal stem cell engraftment in bone following in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005;79:1607-1614.
62. Götherström C, Ringden O, Tammik C et al. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004;190:239-245.
63. Pixley JS, Zanjani ED, Shaft DM et al. Prolonged hematopoietic chimerism in normal mice transplanted in utero with human hematopoietic stem cells. Pathobiology 1998;66:230-239.
64. Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-1286.
65. Bulfield G, Siller WG, Wight PA et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81:1189-1192.
66. Deconinck AE, Rafael JA, Skinner JA et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 997;90:717-727.
67. Cooper BJ, Winand NJ, Stedman H et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988;334:154-156.
68. Phelps SF, Hauser MA, Cole NM et al. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet 1995;4:1251-1258.
69. Wells DJ, Wells KE, Asante EA et al. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum Mol Genet 1995;4:1245-1250.
70. Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004;144(5 Suppl):S27-S34.
71. Nathwani AC, Davidoff AM, Tuddenham EG. Prospects for gene therapy of haemophilia. Haemophilia 2004;10:309-318. 4